AU2001288250A1 - Methods for treating subjects infected with a herpes virus or neisseria gonorrheae - Google Patents

Methods for treating subjects infected with a herpes virus or neisseria gonorrheae

Info

Publication number
AU2001288250A1
AU2001288250A1 AU2001288250A AU8825001A AU2001288250A1 AU 2001288250 A1 AU2001288250 A1 AU 2001288250A1 AU 2001288250 A AU2001288250 A AU 2001288250A AU 8825001 A AU8825001 A AU 8825001A AU 2001288250 A1 AU2001288250 A1 AU 2001288250A1
Authority
AU
Australia
Prior art keywords
tolan
hydroxylated
hsv
infection
infected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288250A
Other languages
English (en)
Inventor
John Docherty
Chun-Che Tsai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeast Ohio Medical University
Kent State University
Original Assignee
Northeast Ohio Medical University
Kent State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Ohio Medical University, Kent State University filed Critical Northeast Ohio Medical University
Publication of AU2001288250A1 publication Critical patent/AU2001288250A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2001288250A 2000-08-15 2001-08-15 Methods for treating subjects infected with a herpes virus or neisseria gonorrheae Abandoned AU2001288250A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22560900P 2000-08-15 2000-08-15
US60/225,609 2000-08-15
PCT/US2001/025466 WO2002013764A2 (en) 2000-08-15 2001-08-15 Methods for treating subjects infected with a herpes virus or neisseria gonorrheae

Publications (1)

Publication Number Publication Date
AU2001288250A1 true AU2001288250A1 (en) 2002-02-25

Family

ID=22845537

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288250A Abandoned AU2001288250A1 (en) 2000-08-15 2001-08-15 Methods for treating subjects infected with a herpes virus or neisseria gonorrheae

Country Status (6)

Country Link
US (2) US6599945B2 (ja)
EP (1) EP1311254A2 (ja)
JP (1) JP2004505998A (ja)
AU (1) AU2001288250A1 (ja)
CA (1) CA2423337A1 (ja)
WO (1) WO2002013764A2 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599945B2 (en) * 2000-08-15 2003-07-29 Northeastern Ohio Universities College Of Medicine Methods for treating subjects infected with a herpes virus
US20070082035A1 (en) * 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
US7678819B2 (en) * 2006-12-07 2010-03-16 The Trustees Of The University Of Pennsylvania Acetylene derivatives and their use for binding and imaging amyloid plaques
WO2008157787A2 (en) * 2007-06-20 2008-12-24 Kent State University Hydroxylated tolans and related compounds in the treatment of cancer
WO2008157745A1 (en) * 2007-06-20 2008-12-24 Kent State University Ascorbate, vitamin k3 and hydroxytolans in the treatment of cancer
EP2456306A4 (en) 2009-07-20 2012-12-26 Summa Health System VITAMIN C AND VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING OESTOLYSIS OR EXTENDING A PROTEST IMPLANT
WO2011009888A2 (en) * 2009-07-22 2011-01-27 Dsm Ip Assets B.V. Process for the production of substituted electron rich diphenylacetylenes
US20150272924A1 (en) 2012-11-08 2015-10-01 Summa Health System Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
KR20170141705A (ko) 2015-04-08 2017-12-26 바이오멘딕스, 엘엘씨 상처 치유를 조절하기 위한 제형 및 방법
EP3249406A1 (de) * 2016-05-27 2017-11-29 PerkinElmer Cellular Technologies Germany GmbH Verfahren zur bestimmung der anzahl von infektionsherden einer zellkultur
KR102620652B1 (ko) * 2017-07-27 2024-01-03 바이오멘딕스, 엘엘씨 미생물 콜로니화의 조절을 위한 치환된 톨란

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE280030C (ja)
US4001137A (en) * 1971-08-07 1977-01-04 Merck Patent Gesellschaft Mit Beschrankter Haftung Nematic compounds and mixtures
FR2213803B2 (ja) * 1973-01-12 1976-11-05 Thomson Csf
US4153509A (en) * 1977-10-17 1979-05-08 Union Carbide Corporation Microbial production of hydroxylated biphenyl compounds
DD280030A1 (de) * 1989-02-24 1990-06-27 Bitterfeld Chemie Mittel zum schutz von kultur- und nutzpflanzen gegen viren
US5420361A (en) * 1992-02-05 1995-05-30 Bio-Technical Resources Formulation of and dehydration of hydroxylated diphenyl acetylenes
US6197834B1 (en) 1998-09-01 2001-03-06 Northeastern Ohio Universities College Of Medicine Method of inhibiting formation of infectious herpes virus particles
US6599945B2 (en) 2000-08-15 2003-07-29 Northeastern Ohio Universities College Of Medicine Methods for treating subjects infected with a herpes virus

Also Published As

Publication number Publication date
EP1311254A2 (en) 2003-05-21
US20030203974A1 (en) 2003-10-30
CA2423337A1 (en) 2002-02-21
US20020103262A1 (en) 2002-08-01
US6599945B2 (en) 2003-07-29
JP2004505998A (ja) 2004-02-26
WO2002013764A3 (en) 2002-07-25
WO2002013764A2 (en) 2002-02-21
US7094809B2 (en) 2006-08-22

Similar Documents

Publication Publication Date Title
CA2342582C (en) A method of inhibiting formation of infectious herpes virus particles
US5952392A (en) Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6599945B2 (en) Methods for treating subjects infected with a herpes virus
AU762860B2 (en) Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies
EP0557404B1 (fr) UTILISATION ANTIVIRALE DE COMPOSE 2,6-DI-t-BUTYLPHENOL SUBSTITUE EN POSITION 4, NOTAMMENT VIS-A-VIS DES VIRUS DE L'HERPES ET DES PAPILLOMAVIRUS
JP3739098B2 (ja) 長鎖アルコール類、アルカン類、脂肪酸類およびアミド類によるウイルスの阻害
US6406706B1 (en) Use of α- and β-santalols major constituents of sandal wood oil, in the treatment of warts, skin blemishes and other viral-induced tumors
IL267914A (en) compounds and preparations
US7037945B2 (en) Method of inhibiting formation of Neisseria gonorrhea and Neisseria meningiditis
KR20140145021A (ko) 붕산, 구연산, 아연, 알부민 및 비타민 c를 포함하는 파필로마 바이러스에 대한 항바이러스 피부외용제 조성물
CN1056774C (zh) “克疣淋”消毒杀菌剂
EP2629765B1 (en) Methods and compositions for treating pox virus infections with an 1,4-naphthoquinone as active agent
US20040235931A1 (en) Inhibition of herpes virus replication
WO2024028914A1 (en) Pharmaceutical composition for the treatment and prevention of hpv

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application